Nick Haining
@nickhaining
CSO and co-founder of @ArsenalBio via @DanaFarber, @broadinstitute, and @Merck. He/his.
ID: 81903624
12-10-2009 19:01:16
1,1K Tweet
3,3K Followers
1,1K Following
Our CEO ken drazan, MD, was featured in Cell&Gene this morning! Hear Ken’s take on ArsenalBio’s pioneering approach and role in the future of engineering CAR-T #celltherapies in the Q&A by Erin Harris here: cellandgene.com/doc/computatio… #EngineeredToCure
Grateful for this opportunity to keep raising the bar for better engineered T cell therapies for patients with cancer. Can't wait to share what we're building. ArsenalBio fiercebiotech.com/biotech/bms-ba…
Our latest paper is out in Nature Immunology. This work represents a years-long effort from Juan Dubrot Peter Du, Kathleen Yates Sarah Lane-Reticker and others to identify immune evasion genes using in vivo #CRISPRscreens in mouse cancer models treated with ICB. rdcu.be/cWcrJ
Go Deb go! Well deserved award to Debattama Sen We’re going to learn a lot about the wiring of T cells from the Sen lab.
Four years ago, the founders had a bunch of ideas on a whiteboard and not much else. Today, ArsenalBio has dosed the first patient with AB-1015, an engineered autologous T cell therapy for ovarian cancer. Incredibly proud of what the Arsenal team has accomplished. Onwards.
Well deserved award to a thoughtful and original scientist who has helped us all understand a lot about how T cells work and don’t work. Congrats E. John Wherry !
There’s some really awesome science going on at ArsenalBio — come and meet the brainiacs building tomorrow’s cell therapy today at #AACR23 businesswire.com/news/home/2023…